These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

503 related articles for article (PubMed ID: 17975187)

  • 21. Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis.
    Baker WL; Baker EL; Coleman CI
    Pharmacotherapy; 2009 Aug; 29(8):891-905. PubMed ID: 19637942
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Triple Therapy versus Dual or Monotherapy with Long-Acting Bronchodilators for Chronic Obstructive Pulmonary Disease. A Systematic Review and Meta-analysis.
    Mammen MJ; Lloyd DR; Kumar S; Ahmed AS; Pai V; Kunadharaju R; Gupta S; Nici L; Aaron SD; Alexander PE
    Ann Am Thorac Soc; 2020 Oct; 17(10):1308-1318. PubMed ID: 32692253
    [No Abstract]   [Full Text] [Related]  

  • 23. Medications for COPD: a review of effectiveness.
    Grimes GC; Manning JL; Patel P; Via RM
    Am Fam Physician; 2007 Oct; 76(8):1141-8. PubMed ID: 17990836
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of inhaled corticosteroids /long-acting agonists in a single inhaler versus inhaled corticosteroids alone on all-cause mortality, pneumonia, and fracture in chronic obstructive pulmonary disease: A nationwide cohort study 2002-2013.
    Cho KH; Kim YS; Linton JA; Nam CM; Choi Y; Park EC
    Respir Med; 2017 Sep; 130():75-84. PubMed ID: 29206637
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined inhaled anticholinergics and short-acting beta2-agonists for initial treatment of acute asthma in children.
    Griffiths B; Ducharme FM
    Cochrane Database Syst Rev; 2013 Aug; (8):CD000060. PubMed ID: 23966133
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of roflumilast in COPD patients receiving inhaled corticosteroid/long-acting β2-agonist fixed-dose combination: RE(2)SPOND rationale and study design.
    Rennard SI; Martinez FJ; Rabe KF; Sethi S; Pizzichini E; McIvor A; Siddiqui S; Anzueto A; Zhu H
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1921-8. PubMed ID: 27574416
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Long-term treatment strategy in chronic obstructive pulmonary disease: how to change the course of the disease].
    Devillier P; Salvator H; Roche N; Grassin-Delyle S; Naline E; Dorocant S; Neveu H
    Presse Med; 2014 Dec; 43(12 Pt 1):1368-80. PubMed ID: 25455634
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Meta-analysis: anticholinergics, but not beta-agonists, reduce severe exacerbations and respiratory mortality in COPD.
    Salpeter SR; Buckley NS; Salpeter EE
    J Gen Intern Med; 2006 Oct; 21(10):1011-9. PubMed ID: 16970553
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-acting bronchodilator therapy for the treatment of chronic obstructive pulmonary disease.
    Chen AM; Bollmeier SG; Finnegan PM
    Ann Pharmacother; 2008 Dec; 42(12):1832-42. PubMed ID: 18957624
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beclometasone for chronic obstructive pulmonary disease.
    De Coster DA; Jones M; Thakrar N
    Cochrane Database Syst Rev; 2013 Oct; 2013(10):CD009769. PubMed ID: 24105424
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative safety and effectiveness of long-acting inhaled agents for treating chronic obstructive pulmonary disease: a systematic review and network meta-analysis.
    Tricco AC; Strifler L; Veroniki AA; Yazdi F; Khan PA; Scott A; Ng C; Antony J; Mrklas K; D'Souza J; Cardoso R; Straus SE
    BMJ Open; 2015 Oct; 5(10):e009183. PubMed ID: 26503392
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhaled short-acting beta2-agonists versus ipratropium for acute exacerbations of chronic obstructive pulmonary disease.
    McCrory DC; Brown CD
    Cochrane Database Syst Rev; 2001; 2001(2):CD002984. PubMed ID: 11406052
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhaled corticosteroids for stable chronic obstructive pulmonary disease.
    Yang IA; Fong KM; Sim EH; Black PN; Lasserson TJ
    Cochrane Database Syst Rev; 2007 Apr; (2):CD002991. PubMed ID: 17443520
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optimizing treatment of chronic obstructive pulmonary disease: an assessment of current therapies.
    Wise RA; Tashkin DP
    Am J Med; 2007 Aug; 120(8 Suppl 1):S4-13. PubMed ID: 17678942
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Short-acting beta 2 agonists for stable chronic obstructive pulmonary disease.
    Sestini P; Renzoni E; Robinson S; Poole P; Ram FS
    Cochrane Database Syst Rev; 2002; (4):CD001495. PubMed ID: 12519559
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined corticosteroid and long acting beta-agonist in one inhaler for chronic obstructive pulmonary disease.
    Nannini L; Cates CJ; Lasserson TJ; Poole P
    Cochrane Database Syst Rev; 2004; (3):CD003794. PubMed ID: 15266502
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhaled corticosteroids in chronic obstructive pulmonary disease: is there a clinical benefit?
    Man SF; Sin DD
    Drugs; 2005; 65(5):579-91. PubMed ID: 15748094
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of inhaled long-acting β-agonist and anticholinergic effectiveness in older patients with chronic obstructive pulmonary disease: a cohort study.
    Gershon A; Croxford R; To T; Stanbrook MB; Upshur R; Sanchez-Romeu P; Stukel T
    Ann Intern Med; 2011 May; 154(9):583-92. PubMed ID: 21536937
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combination therapy of inhaled corticosteroids and long-acting beta2-adrenergics in management of patients with chronic obstructive pulmonary disease.
    Sin DD; Johnson M; Gan WQ; Man SF
    Curr Pharm Des; 2004; 10(28):3547-60. PubMed ID: 15579052
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.